Bloomberg Law | Vaccine IP Waiver Plan Redo “Has Legs” but Devil’s in the Detail

The Biden Administration announced its global vaccine assistance plan. In addition, the FDA issued a series of guidance documents for the Drug Supply Chain Security Act (DSCSA). Read the details in the COVID-19 Medical Products Supply Chain Week in Review.

The FDA revealed the future plan for its inspectional activities. President Biden announced a new July 4 vaccination target. Read the details in the COVID-19 Medical Products Supply Chain Week in Review.

Matt Howell is quoted on the legal options available to vaccine producers if their COVID-19 vaccine patents are waived by the government.

Matt Howell is quoted on issues concerning COVID-19 vaccine intellectual property enforcement and possible future litigation.

Matt Howell comments on potential patent litigation over COVID-19 vaccines and other technologies.